When was Alzheimers Drug Discovery Foundation founded?

Alzheimers Drug Discovery Foundation was founded in 1998.

Where is Alzheimers Drug Discovery Foundation headquartered?

Alzheimers Drug Discovery Foundation is headquartered in New York, NY.

What is Alzheimers Drug Discovery Foundation's total asset value?

Alzheimers Drug Discovery Foundation has around in total assets under management.

How many investments has Alzheimers Drug Discovery Foundation made?

Alzheimers Drug Discovery Foundation has made 78 investments.

What has Alzheimers Drug Discovery Foundation invested in?

Alzheimers Drug Discovery Foundation has made numerous investments in companies like Therini Bio , Modulo Bio , and GLX Analytix within the Drug Discovery, Discovery Tools (Healthcare), and Biotechnology industries.

What has Alzheimers Drug Discovery Foundation invested in recently?

Alzheimers Drug Discovery Foundation's latest investment was on 14-May-2025 in Therini Bio , a company within the Drug Discovery industry.

Alzheimers Drug Discovery Foundation investment portfolio

Alzheimers Drug Discovery Foundation Overview

Investor Type

Venture Capital

Status

Active

Professionals

3

Investments

78

Portfolio

44

Exits

13

Alzheimers Drug Discovery Foundation General Information

Company Description

Founded in 1998, Alzheimers Drug Discovery Foundation is an investment firm based in New York, New York. The firm seeks to invest in the healthcare sector by giving awards to companies.

Business Details

Website

alzdiscovery.org

Year Founded

1998

Investor Status

Actively Seeking New Investments

Trade Association

National Venture Capital Association (NVCA)

Primary Investor Type

Not-For-Profit Venture Capital

Corporate Office

57 West 57th Street
Suite 904
New York, NY 10019
United States

+1 (212)







Alzheimers Drug Discovery Foundation Investments (78)

Company Name	Deal Date	Deal Type	Industry	Company Stage
Therini Bio	14-May-2025	Later Stage VC	Drug Discovery	Clinical Trials - Phase 1
Modulo Bio	19-Mar-2025		Discovery Tools (Healthcare)	Generating Revenue
GLX Analytix	23-Oct-2024		Biotechnology	Generating Revenue
C2N Diagnostics	30-Sep-2024		Laboratory Services (Healthcare)	Generating Revenue
NeuroTherapia	06-Aug-2024		Drug Discovery	Clinical Trials - Phase 2
Coya Therapeutics	15-May-2024		Biotechnology	Generating Revenue/Not Profitable
Vaccinex	29-Mar-2024		Biotechnology	Generating Revenue/Not Profitable
NeuroAge Therapeutics	01-Feb-2024		Biotechnology	Product In Beta Test
Superfluid DX	20-Dec-2023	Later Stage VC	Drug Discovery	Generating Revenue
Cognito Therapeutics	15-Nov-2023	Later Stage VC	Biotechnology	Generating Revenue

You’re viewing 10 of 78 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alzheimers Drug Discovery Foundation Exits (13)

Company Name	Exit Date	Exit Type
Lexeo Therapeutics	03-Nov-2023	IPO
GliaCure	13-Jun-2023
ADx NeuroSciences	08-Aug-2022
Amylyx	07-Jan-2022
NeuroLucent	27-Dec-2021
Cognition Therapeutics	08-Oct-2021
Athira Pharma	18-Sep-2020
Tetra Therapeutics	05-Mar-2020
Rodin Therapeutics	25-Nov-2019	Merger/Acquisition
AlzeCure Pharma	28-Nov-2018	IPO

You’re viewing 10 of 13 exits. Get the full list »

Alzheimers Drug Discovery Foundation Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.